Exploring different imaging technologies for prostate cancer

Dr. Baowei Fei’s research on prostate cancer imaging has been featured by SciTech Europa Quarterly that provides opportunities to leading figures from across Europe to discuss current and future projects, policy change and future priorities within research and development, as well as being a platform for others to voice their opinions and showcase their results to Europe’s research community. For more information, read the PDF file of the article or visit the following websites:

Researchers at UT Dallas advance fight to end cancer

Community Impact Newspaper reported the cancer research work that were conducted at the University of Texas at Dallas. Community Impact Newspaper is vested in the communities and has dedicated reporters in each community who attend city council and school board meetings. Community Impact Newspaper distributes hyperlocal news and information to millions of local residents and business owners each day online and monthly by mail. For more information, read the article from the following website:

Novel Imaging Technique and AI Create Smart Microscope for Cancer Surgery

Dr. Baowei Fei and his group have recently used a unique imaging technology and artificial intelligence (AI) to predict the presence of cancer cells in tissue samples. This hyperspectral imaging technique is effective in satellite imagery and orbiting telescopes. It could be used to quickly identify cancer cells in the operating room as well. Analyzing 293 tissue samples from 102 head and neck cancer surgery patients, Fei and colleagues found that hyperspectral imaging and AI could be used to predict cancer cell presence with 80-90% accuracy. Dr. Fei recently received a $1.6 million grant from the Cancer Prevention & Research Institute of Texas (CPRIT) to continue improving this smart surgical microscope. Once this approach is fully developed, it would need to be tested in clinical studies before being used in the live healthcare environment. For more information, visit the following website: